10x Genomics, SCRUM Collaborate
News Sep 16, 2016
10x Genomics, Inc. has announced that it has entered into distribution agreement with SCRUM Inc. to bring the Chromium™ System and associated products to the rapidly expanding Japanese market. “With the addition of our new Japanese partner, 10x has successfully inked distribution arrangements throughout the Asia Pacific region, a growing market that is hungry for new and more powerful sequencing solutions,” said Serge Saxonov, Ph.D., co-founder and chief executive officer of 10x Genomics.
“Having analyzed a number of exceptional partnering opportunities in the region, we are pleased to be working with SCRUM Inc. to deliver these new capabilities to our current and future customers in Japan.” The company’s recently launched Chromium System is a microfluidics-based molecular barcoding system, built upon their proprietary GemCode™ Technology. The single instrumentation system can run multiple, powerful applications, including the Chromium Genome and Exome Solutions, which both provide novel long-range genomic data called “linked-reads.”
The Chromium workflows utilize a customer’s existing short-read sequencer, and enable more expansive characterization of previously inaccessible genomic information. In addition, the Chromium Single Cell Solution allows for high-throughput, deep profiling of complex cell populations through single-cell gene expression analysis. “The value of 10x Genomics’ platform has already been well validated by many genomic researchers and commercial research organizations,” said Takemitsu Furuta, executive director, business development of SCRUM.
“We recently held a Chromium System seminar and received overwhelmingly positive feedback from potential users, which reiterates our confidence that this system has the ability to positively impact the efficiency and quality of our customers’ research.” In May of this year, 10x announced key distribution agreements with MDxK, Inc., Millennium Science Pty Ltd, Research Instruments Pte Ltd and Star Research Technology Ltd., in South Korea, Australia and New Zealand, Southeast Asia and China respectively.
Test For Designer Drugs Could Help Treat Overdose PatientsNews
Medical professionals are scrambling to meet the growing demand for emergency room treatment, but they’re hampered by the lack of a quick and easy test to screen patients for “designer” drugs. Chemists have now developed such a test and are refining it with the hope that hospitals could eventually use it to choose the appropriate treatment.READ MORE
Measuring Neutrophil Motility Could Lead to Accurate Sepsis DiagnosisNews
Mass. General researchers design device that rapidly diagnoses sepsis with more than 95 percent accuracy.READ MORE
Switch Discovered to Convert Blood Vessels to Blood Stem Cells During Embryonic DevelopmentNews
Findings could aid research into creating new blood cells for transplants and understanding cancer metastasis.READ MORE